2015 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2008 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2015 | 0 | 4.835.584 | 323.625 | 1 | ||
2013 | 0 | 9.833.348 | 614.584 | 1 | ||
2011 | 0 | 2.995.104 | 161.280 | 1 |
Total number of partners: 36
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 36
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2015-05-01 | Laser Multiplexed Biosensor | GLAM | participant | 4.835.584 | 10 |
2013-02-01 | Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility | NANOATHERO | participant | 9.833.348 | 16 |
2011-10-01 | Gaining sage on the Epoetins' saga: assessing long term risks and advancing towards better Epoetin driven treatment modalities | EpoCan | participant | 2.995.104 | 13 |